Open access · US-GOV
via ClinicalTrials.gov Clinical trial
CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss
Authors not listed
Gali Perel · 2026
Abstract
People with advanced cancer often lose muscle over time. This can make them weaker, more tired, and reduce their quality of life. Many patients also struggle to eat because of changes in taste, smell, or appetite.
This study evaluates a new way to help slow muscle loss and support daily functioning.
The approach combines personalized food and cooking guidance with close nutrition demands support. The goal is to help patients eat better in a way that fits their personal needs.
It is hypothesized that this close, personalized treatment improves muscle loss and the quality of life of adults with advanced cancer who are receiving chemotherapy.
The study focuses on people with mild to moderate muscle mass loss currently undergoing or about to start chemotherapy and aims to slow further decline in their muscle mass.
The approach is designed to be practical and suitable for everyday life during cancer treatment.
About 200 adults with advanced cancer who are receiving, or about to receive, chemotherapy will take part in this study.
The study will take place at the Davidoff Cancer Center in Israel and will last 6 months.
Participants will be randomly assigned to one of two groups. One group will receive standard nutrition care from dietitians as well as ongoing physical activities programing and monitoring.
The other group will receive the same care, plus personalized cooking and food guidance tailored to their taste and smell changes. This group will also receive care based on careful measurements of their body's energy needs, body composition, and muscle strength.
These measurements will help the dietitian to offer more precise and personalized nutrition guidance over time.
Both groups will also receive advice about physical activity. Researchers will follow changes in muscle strength, physical function, nutrition status, and quality of life during the study.
The results will help determine whether personalized food and cooking support can better protect muscle mass and well-being in people with advanced cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2026). CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss. <em>Gali Perel</em>. https://clinicaltrials.gov/study/NCT07466862
Vancouver
Anonymous. CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss. Gali Perel. 2026.
BibTeX
@misc{anon2026CuliCa,
title = {CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss},
author = {Anonymous},
journal = {Gali Perel},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 2026
Open access · US-GOV
Efficacy of a Sarcopenia Screening Program in Subjects With Advanced Coxarthrosis. SARCO-COX Randomized Intervention Study
Copenhagen University Hospital, Rigshospitalet 2023
Open access · US-GOV
Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer
King Edward Medical University 2026
Open access · US-GOV
Telemedicine-Delivered Nutritional Counseling Versus Standard Care for Cancer Cachexia in Pakistani Cancer Patients: A Pilot Randomized Controlled Trial
National Taiwan University Hospital 2025
Open access · US-GOV
Improving Sarcopenia During Chemotherapy
Ankara Etlik City Hospital 2022
Open access · US-GOV
Inflammatory, Nutritional, and Sarcopenia-Based Prediction of Pathological Response in Local Advanced Rectal Cancer: A Regression and AI Approach
University of Ulster 2022
Open access · US-GOV